Hemodynamic changes associated with LMA insertion. Encounter for other preprocedural examination
Conditions
Interventions
Intervention 1: Intervention group: Patients aged 18 to 50 years who are classified as ASA I or ASA II will be divided into two groups. In both groups, anesthesia will be induced with similar medicati
Sponsors
Bandare-abbas University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Patients volunteering for upper limb orthopedic procedures Age between 18 and 50 years Physical status ASA Class I or II according to the American Society of Anesthesiologists
Exclusion criteria
Exclusion criteria: History of cardiovascular disease, uncontrolled blood pressure, or known arrhythmia Chronic respiratory disease or anticipated difficulty in intubation Hypersensitivity or allergy to lidocaine or other local anesthetics Pregnancy or lactation Use of medications affecting hemodynamic responses (such as beta-blockers or tricyclic antidepressants) Hepatic or renal failure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood pressure changes in response to different routes of lidocaine administration. Timepoint: Before the intervention and at 1, 3, 5, and 10 minutes after LMA insertion. Method of measurement: Monitoring device (operating room monitor).;Heart rate changes in response to different routes of lidocaine administration. Timepoint: Before the intervention and at 1, 3, 5, and 10 minutes after LMA insertion. Method of measurement: Monitoring device (operating room monitor).;O2 saturation(SPO2) changes in response to different routes of lidocaine administration. Timepoint: Before the intervention and at 1, 3, 5, and 10 minutes after LMA insertion. Method of measurement: Monitoring device (operating room monitor). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSaeedeh Besharatifar
Bandare-abbas University of Medical Sciences
Outcome results
None listed